Payment for Smallpox Vaccine
Faces Fire From Drug Makers

Even before the U.S. government has chosen the drug makers to mass-produce a smallpox vaccine, the price the government proposes to pay for the 250 million doses is coming under fire.

GlaxoSmithKline PLC, one of the four finalists, said the company would have a hard time covering the cost of making the smallpox vaccine for the $509 million the government plans to pay. "It would be very challenging to meet the government's...